Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
JUN, known as transcription factor Jun or c-Jun, is a basic leucine zipper (bZIP) transcription factor and proto-oncogene that functions as a key component of the AP-1 transcription factor complex by dimerizing with Fos and other partners. JUN/AP-1 modulates gene expression in response to a wide range of extracellular signals—growth factors, cytokines, cellular stress, and UV—and mediates cellular outcomes such as proliferation, cell cycle control, apoptosis, immunity, and metabolic adaptation. Dysregulated JUN expression and activation are implicated in several types of cancer (notably acute myeloid leukemia and breast cancer), inflammation, and stress-related diseases, often through altered regulation of downstream effectors like the glutaminase gene GLS and Unfolded Protein Response mediators. Therapeutic targeting of JUN involves either direct inhibition of its activity (AP-1 complex formation, DNA binding) or modulation of upstream kinases, but remains challenging due to the physiological importance of JUN in normal cell function.
Blockade of dimerization (prevents formation of functional AP-1 complex, thus inhibiting DNA binding and target gene activation) Inhibition of phosphorylation via upstream kinases (JNK, ERK), preventing activation of c-Jun and its transcriptional programs Suppression of downstream transcriptional events (e.g., inhibition of the Unfolded Protein Response, glutaminase expression)
2 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Transcription factor Jun (specifically, the c-Jun subunit of the AP-1 complex) (JUN).